CONEXEU SCIENCES INC. Other Executive Compensation Disclosures
Every other executive-compensation XBRL fact the company filed (policies, award timing, footnotes, adjustments), newest first. Long text is shortened; the filing has the full text.
- 2026-09-14: Disclosure Material Terms Of Trading Arrangement; Period 2025-11-01..2026-07-31; Value During our fiscal quarter ended July 31, 2026, none of our directors or executive officers adopted, modified or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any &qu….
- 2026-09-14: Disclosure Trading Arrangement Individual Title; Period 2025-11-01..2026-07-31; Value directors or executive officers.
- 2026-09-14: Disclosure Non Rule10b51Arr Adopted; Period 2025-11-01..2026-07-31; Value No.
- 2026-09-14: Disclosure Rule10b51Arr Adopted; Period 2025-11-01..2026-07-31; Value No.
| Filed | Disclosure | Qualifiers | Period | Value |
|---|---|---|---|---|
| 2026-09-14 10-Q | Material Terms Of Trading Arrangement | 2025-11-01..2026-07-31 | During our fiscal quarter ended July 31, 2026, none of our directors or executive officers adopted, modified or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any &qu… | |
| 2026-09-14 10-Q | Trading Arrangement Individual Title | 2025-11-01..2026-07-31 | directors or executive officers | |
| 2026-09-14 10-Q | Non Rule10b51Arr Adopted | 2025-11-01..2026-07-31 | No | |
| 2026-09-14 10-Q | Rule10b51Arr Adopted | 2025-11-01..2026-07-31 | No | |
| 2026-09-14 10-Q | Non Rule10b51Arr Terminated | 2025-11-01..2026-07-31 | No | |
| 2026-09-14 10-Q | Rule10b51Arr Terminated | 2025-11-01..2026-07-31 | No | |
| 2026-06-15 10-Q | Material Terms Of Trading Arrangement | 2025-11-01..2026-04-30 | During our fiscal quarter ended April 30, 2026, none of our directors or executive officers adopted , modified or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any &… | |
| 2026-06-15 10-Q | Trading Arrangement Individual Title | 2025-11-01..2026-04-30 | none | |
| 2026-06-15 10-Q | Non Rule10b51Arr Adopted | 2025-11-01..2026-04-30 | No | |
| 2026-06-15 10-Q | Rule10b51Arr Adopted | 2025-11-01..2026-04-30 | No | |
| 2026-06-15 10-Q | Non Rule10b51Arr Terminated | 2025-11-01..2026-04-30 | No | |
| 2026-06-15 10-Q | Rule10b51Arr Terminated | 2025-11-01..2026-04-30 | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |